1. Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina.
- Author
-
Hori, Tesshu, Fukutome, Masashi, Maejima, Chiseto, Matsushima, Hiroki, Kobayashi, Kensuke, Kitazawa, Soichiro, Kitahara, Ryo, Kitano, Katsunori, Kobayashi, Kenta, Moritoh, Satoru, and Koike, Chieko
- Abstract
Adeno-associated virus (AAV) has been studied as a safe delivery tool for gene therapy of retinal blinding diseases such as Leber's congenital amaurosis (LCA). The tropism of recombinant AAV (rAAV) including its specificity and efficiency in targeting retinal cell types has been studied with native or engineered capsids, along with specific promoters. However, one of the rAAV serotypes, rAAV2/6, has not been well-studied based on a report of low infection efficiency in the retina. We investigated the tropism of several rAAVs by subretinal injection in the adult mouse and found that rAAV2/6 predominantly infected cone photoreceptors including the main spectral type. Our data suggest that subretinal injection with rAAV2/6 may provide both an efficacious and specific means of gene delivery to cone photoreceptors in murine retinas. Image 1 • Cone photoreceptors are targets for gene therapy for diseases such as mid-stage retinitis pigmentosa and achromatopsia. • rAAV has been considered as an effective and safe delivery tool for gene therapy in the retina. • The tropism of rAAV2/6 has been studied in the retina but not in detail. • We show that subretinally injected rAAV2/6 predominantly infects cone photoreceptors as opposed to rods. • Our results suggest that AAV2/6 may be an appropriate vector for introducing therapeutic genes into cones. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF